Background Since the initial recognition of autoimmune pancreatitis (AIP), elevated serum IgG4 levels and increased numbers of IgG4-positive plasma cells in tissues have been regarded as diagnostic hallmarks of the disorder. However, the role of the IgG4 level in other non-AIP IgG4-RD is unclear.
Objectives To investigate the clinical features and factors associated with IgG4 test positivity over an 8-year period in 166 patients with IgG4-related diseases (IgG4-RD).
Methods The medical records of 2,968 adult subjects who underwent serum IgG4 level tests conducted between December 2007 and August 2014 were reviewed.
Results Among 2,968 patients, 166 (5.6%) were diagnosed with IgG4-RD and 2,802 (94.4%) were determined to have other diseases (non-IgG4-RD group). The mean IgG4 level in subjects with IgG4-RD was 1087.5 mg/dL (median: 597.0, range: 15–6790 mg/dL), which was significantly higher than that of subjects with non-IgG4-RD (mean: 104.1, median: 75.0, range: 1–4400 mg/dL; p<0.0001). Among the 166 IgG4-RD patients, the mean age was 58.5 ± 15.9 years (range: 21–87). Of 166 patients with IgG4-RD, 87 (52.4%) had an IgG4-RD other than autoimmune pancreatitis (non-AIP IgG4-RD). Twenty-seven out of 166 IgG4-RD (16.3%) patients had other organ involvement (OOI) outside of the pancreatobiliary system. IgG4 levels were elevated (>135 mg/dL) in 143 (86.1%) of 166 patients with IgG4-RD and in 652 (23.3%) of 2,802 patients with non-IgG4-RD (p<0.001). The present study showed that the best IgG4 cutoff was 222 mg/dL for the diagnosis of IgG4-RD.
Conclusions In the present study, we demonstrated that more than half of the diseases associated with IgG4-RD were non-AIP IgG4-RD. Among the 166 IgG4-RD patients, the manifestations covered the full range of organ system involvement. Moreover, the best IgG4 cutoff (measured with nephelometry using a Siemens BN ProSpec instrument and Siemens reagent) was 222 mg/dL for IgG4-RD.
Disclosure of Interest None declared
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.